Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Focus of the Report: The use of radiofrequency ablation (RFA) of the genicular nerves for the treatment of osteoarthritis of the knee (KOA).

Technology Description: In this report, RFA is defined as ablation of the peripheral nerves of the knee to relieve the pain associated with KOA. The genicular nerves supply the knee and include the articular branches of the obturator, femoral, saphenous, common peroneal, and tibial nerves. During RFA, radiofrequency energy delivers heat to the target nerve, thereby creating a lesion that stops pain input to the central nervous system.

Controversy: Uncertainty remains for the use of RFA due to the lack of standardization in procedural techniques, and there are currently no established treatment guidelines that recommend the use of RFA for KOA (Ajrawat et al., 2020). Additionally, the effects of RFA in general are temporary and generally limited to 1 year, as pain signal transmission will return with peripheral nerve regrowth and regeneration (Kidd et al., 2019).

Key Questions:

  • Is RFA of the genicular nerves effective in treating the pain associated with KOA?

  • How does RFA of the genicular nerves compare with clinical alternatives for pain associated with KOA?

  • Is treatment with RFA of the genicular nerves safe?

  • Have definitive patient selection criteria been identified for RFA of the genicular nerves?

If you have a Hayes login, click here to view the full report on the Knowledge Center.